There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...
News-Medical.Net on MSN
Drinking orange juice daily may fine-tune genes tied to cardiovascular wellness
Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...
Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...
Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...
Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.
Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback